Evidence map›Paper›PMID 41988852›Full record

ReviewCancer biology & medicine2026

Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer.

Mingyue Zhao, Rui Chen, Ping Gao

Abstract readReview
In one paragraph

Review in Cancer biology & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mingyue Zhao *Medical Research Institute, Guangdong Provincial People's Hospital, Academy of Medical Sciences, Southern Medical University, Guangzhou 510000, China.ORCID 0000-0002-5173-9820
Rui Chen *Medical Research Institute, Guangdong Provincial People's Hospital, Academy of Medical Sciences, Southern Medical University, Guangzhou 510000, China.
Ping GaoMedical Research Institute, Guangdong Provincial People's Hospital, Academy of Medical Sciences, Southern Medical University, Guangzhou 510000, China.ORCID 0000-0002-6930-7989

Funding

National Natural Science Foundation of China 82130087National Natural Science Foundation of China 82341013National Natural Science Foundation of China 92357301
6 · The paper itself

Abstract

Tumor-associated macrophages (TAMs), essential components of the tumor immune microenvironment (TIME), undergo metabolic reprogramming as part of functional adaptation. Tumor cells modulate TAMs through multiple mechanisms, including metabolic cross-feeding, cytokine production, extracellular vesicles, tumor-derived proteins (such as GRP78) and pathogen-associated patterns (such as Lipopolysaccharide) signaling mediators. In turn, metabolic alterations in TAMs fine-tune TAM function

Indexed as

ImmunotherapyNeoplasmsTumor-Associated MacrophagesAnimalsEndoplasmic Reticulum Chaperone BiPHumansMetabolic ReprogrammingSignal TransductionTumor MicroenvironmentEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanimmunotherapymetabolic rewiringTumor-associated macrophagetumor microenvironment

Identifiers

PMID41988852
PMCPMC13326602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.